ROLE OF BUCCAL FAT PAD DERIVED STROMAL VASCULAR FRACTION(SVF) IN THE TREATMENT OF GUMS DISEASE
Phase 1
- Registration Number
- CTRI/2021/09/036161
- Lead Sponsor
- Genzir Diagnostics
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patient willing to participate for the entire duration of the study and readily available for periodic follow up
patient with good oral hygiene
minimum 20 permanent teeth should be present
furcation defect of 2-4mm
Exclusion Criteria
patient with uncontrolled metabolic diseases, compromised immmune system, pregnancy and prior radiation therapy of surgical site
patient with history of alcoholism, drug abuse and excessive smoking
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method furcation defects will decreaseTimepoint: baseline ,3 months, 6 months
- Secondary Outcome Measures
Name Time Method osseous defects will reduceTimepoint: baseline, 3 months, 6 months